- Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on diabetic peripheral neuropathy: the 3-year, multicenter, comparative Aldose Reductase Inhibitor-Diabetes Complications Trial - (https://pubmed.ncbi.nlm.nih.gov/16801576/ )
- Epalrestat: an aldose reductase inhibitor for the treatment of diabetic neuropathy - (https://pubmed.ncbi.nlm.nih.gov/18447661/)
- Epalrestat. A review of its pharmacology, and therapeutic potential in late-onset complications of diabetes mellitus - (https://pubmed.ncbi.nlm.nih.gov/8312678/ )
- Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: An Indian perspective - (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2771994/)
Alrista (150mg) - Macleods Pharmaceuticals Ltd. (Procare Aht)
Alrista (150mg) Sustained Release Tablet
Generic : Epalrestat
When is Alrista (150mg) prescribed?
It is prescribed for -